How long do patients spend weaning from CPAP in critical care?

Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses
Annette Richardson, Anne Killen

Abstract

The purpose of this project was to audit clinical practice and to investigate the time taken to wean patients using continuous positive airway pressure (CPAP) as a method of respiratory support prior to the introduction of a weaning protocol. Data was collected over a two-month period and 43 patients were included in the audit. Criteria for inclusion were that each patient had previously received mechanical ventilation and was subsequently weaned with the aid of CPAP or had received CPAP and was weaning from CPAP alone. The average time taken to wean was 95 hours (3.96 days) and ranged from one to 41 days. There was no correlation between the length of weaning time and the patient's APACHE II Score or the length of time spent on invasive ventilation prior to weaning on CPAP. However, there was a consistency in the time spent on CPAP as a percentage of the total weaning time. The audit identified large variations in the process and time taken to wean patients from CPAP. This might suggest that CPAP is used in a routine or arbitrary manner rather than a selective response to patients' specific needs.

References

Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·G Le BourdellesM Aubier
Apr 11, 2000·Respiratory Care Clinics of North America·E W Ely
Jul 11, 2000·British Journal of Nursing : BJN·C Brigg
Feb 28, 2002·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Mar 1, 2002·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·A M Price
Dec 19, 2002·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Cheryl Crocker
Jun 27, 2003·American Journal of Respiratory and Critical Care Medicine·Paolo Navalesi
Sep 29, 2004·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·R Endacott

❮ Previous
Next ❯

Citations

Oct 16, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Atsushi KawaguchiDaniel Garros
Apr 26, 2020·Journal of Clinical Medicine·Dejan RadovanovicPierachille Santus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.